2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | AllPubMed

Publications - 2007

Vlodavsky I, Ilan N, Nadir Y, Brenner B, Katz BZ, Naggi A, Torri G, Casu B, Sasisekharan R.
Heparanase, heparin and the coagulation system in cancer progression. Thromb Res. 2007;120 Suppl 2:S112-20. Review. [PMID 18023704]

Raman R & Sasisekharan R. Cooperativity in Glycan-Protein Interactions. Chem Biol. 2007 Aug 24; 14(8):873-874. [PMID 17719484]

Guerrini M, Guglieri S, Naggi A, Sasisekharan R, Torri G. Low molecular weight heparins: structural differentiation by bidimensional nuclear magnetic resonance spectroscopy. Semin Thromb Hemost. 2007 Jul; 33(5):478-87. Review. [17629844]

Yang Y, Macleod V, Dai Y, Khotskaya-Sample Y, Shriver Z, Venkataraman G, Sasisekharan R, Naggi A, Torri G, Casu B, Vlodavsky I, Suva LJ, Epstein J, Yaccoby S, Shaughnessy JD Jr, Barlogie B, Sanderson RD. The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapy. Blood. 2007 Sep 15; 110(6): 2041-8. Epub 2007 May 29. [PMID 17536013]

Sengupta S & Sasisekharan R. Exploiting nanotechnology to target cancer. Brit Jour Cancer 2007 May 7;96(9):1315-9. Epub 2007 Apr 3. [PMID 17406364]

Last Updated: August 13, 2010